Of course, challenges can arise, and not every experience will mirror Sarahs
What we do know is how to create satisfying drinks that people actually enjoy drinking
But while the public conversation focuses on hype and access, plan sponsors are left facing a different kind of challenge: soaring pharmacy costs, misinformation-driven demand, and a prescribing environment with little built-in cost control
If your primary problem is metabolic insulin resistance, weight, irregular ovulation metformin (or a GLP-1) addresses the engine and may also reduce androgens enough on its own
So its pretty likely that theres not going to be a real effect on these other modalities, at least in the initial treatment phase. Dasgupta hopes to see GLP-1s used alongside current treatments, like CPAP